Persistent GB virus C infection is associated with decreased HIV-1 disease progression in the Amsterdam Cohort Study [3]

Journal of Infectious Diseases

Volumn 191, Issue 12, 2005, Pages 2156-2157

  George, Sarah L ^a  

^a SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; HEPATITIS G; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPHOCYTE COUNT; PRIORITY JOURNAL; SEROCONVERSION;

DISEASE PROGRESSION; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HIV INFECTIONS; HUMANS;

EID: 20444382357     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/430504     Document Type: Letter

References (6)

1. Van der Bij AK, Kloosicrbocr N, Frins M, et al. GB virus C coinfection and HIV-1 disease progression: the Amsterdam Cohort Study. J Infect Dis 2005;191:678-85.
2. Geskus RB. On the inclusion of prevalent cases in HIV/AIDS natural history studies through a marker-based estimate of time since seroconversion. Stat Mud 2000;19:1753-69.
3. George SL, Varmaz. D. What you need to know about GB virus C. Curr Gaslroenterol Rep 2005;7:54-62.
4. Williams CF, Klinzman D, Yamashita TE, et al. Persistent GR virus C infection and survival in HIV-infected men. N Engl J Med 2004;350: 981-90.
5. Kalbfleish JD, Prentice RL. The statistical analysis of failure time data. 2nd ed. New York: Wiley, 2002.
6. Bjorkman P, Flamholc L, Naucler A, Molnegren V, Wallmark E, VVidell A. GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS 2004;18:877-86.